EconomyAbbVie skin-disease drug reduces lesions in trial; company eyes weight-loss combination

AbbVie said its experimental drug significantly cut inflammatory lumps and abscesses in people with a chronic skin disease, meeting the main goal of a late-stage study. The company is also considering combining it with a weight-loss treatment.

AbbVieskin disease drugclinical trial

RReuters★★☆☆☆2026-10-22 14:35Original